Outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with systemic therapy without cytoreductive nephrectomy (CN)

被引：0
|
作者：
Richey, S. L. [1 ]
Culp, S. H. [1 ]
Wood, C. G. [1 ]
Corn, P. G. [1 ]
Jonasch, E. [1 ]
Tannir, N. M. [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16035
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cytoreductive nephrectomy for metastatic renal cell carcinoma
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2023, 54 (04) : 270 - 271
  • [42] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Mattigk, Angelika
    Zengerling, Friedemann
    UROLOGIE, 2024, 63 (11): : 1151 - 1154
  • [43] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Margulis, Vitaly
    Matin, Surena F.
    Wood, Christopher G.
    CURRENT OPINION IN UROLOGY, 2008, 18 (05) : 474 - 480
  • [44] Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Chery, Lisly J.
    Karam, Jose A.
    Wood, Christopher G.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (09) : 696 - 703
  • [45] Cytoreductive nephrectomy in metastatic renal cell carcinoma
    Healy, Kelly A.
    Marshall, Fray F.
    Ogan, Kenneth
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (08) : 1295 - 1304
  • [46] IMPACT OF ADVERSE DRUG REACTIONS (ADR) ON SYSTEMIC THERAPY IN PATIENTS (PTS) WITH ADVANCED OR METASTATIC RENAL CELL CARCINOMA (MRCC)
    Marschner, N.
    Muench, A.
    Sauer, U.
    Blumenstengel, K.
    Mueller, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 298 - 298
  • [47] Cytoreductive Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy Era
    Uprety, Dipesh
    Bista, Amir
    Smith, Angela L.
    Vallatharasu, Yazhini
    Marinier, David E.
    ANTICANCER RESEARCH, 2018, 38 (05) : 3013 - 3018
  • [48] Effect of renal embolization in patients with synchronous metastatic renal cell carcinoma: a retrospective comparison of cytoreductive nephrectomy and systemic medical therapy
    Kim, Sung Han
    Kim, Jung Kwon
    Park, Boram
    Joo, Jungnam
    Joung, Jae Young
    Seo, Ho Kyung
    Lee, Kang Hyun
    Chung, Jinsoo
    ONCOTARGET, 2017, 8 (30) : 49615 - 49624
  • [49] Is there a "trial effect" on outcome of patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib?
    Keizman, Daniel
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Boursi, Ben
    Weitzen, Rony
    Hayat, Henry
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Roubinov, Keren
    Carducci, Michael Anthony
    Berger, Raanan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [50] Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN)
    Gunenc, Damla
    Issa, Wadih
    Gerald, Thomas
    Zhou, Qinhan
    Zhang, Song
    Ibezue, I. Chidera
    Bhanvadia, Raj
    Tachibana, Isamu
    Brugarolas, James
    Hammers, Hans
    Qin, Qian
    Kapur, Payal
    Woldu, Solomon
    Gaston, Kris
    Lotan, Yair
    Cadeddu, Jeffrey
    Wang, Andrew Z.
    Margulis, Vitaly
    Zhang, Tian
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
12345